The in vitro susceptibilities of 50 field isolates of Riemerella anatipestifer from ducks to ceftiofur and 16 other commonly used antimicrobials were determined. The MIC 90 values (MIC refers to minimum inhibitory concentrations) for the antimicrobials used in this study are as follows: penicillin was 16 g/ml; ceftiofur was 32 g/ml; cephalothin, chloramphenicol, flumequine, and kanamycin were 64 g/ml; nalidixic acid, nitrofurantoin, and sulfamethoxazole were 128 g/ml; amikacin, ampicillin, gentamicin, lincomycin, spectinomycin, streptomycin, tetracycline, and trimethoprim were Ն256 g/ml. The therapeutic efficacy of ceftiofur against a highly lethal experimental R. anatipestifer infection in ducks was also evaluated. All experimental ducks were infected through the infraorbital sinus with 1 ml of 9 ϫ 10 9 CFU of R. anatipestifer. Ceftiofur (0, 0.25, 0.5, 1, and 2 mg/kg) was injected subcutaneously 5 hours after infection. A single dose of 2 mg/kg resulted in 73% survival as compared with 10% survival in the infected, but untreated controls.
Riemerella anatipestifer is a major bacterial pathogen of ducks in Taiwan and other countries causing a disease variously known as infectious serositis, new duck disease, duck septicemia, or anatipestifer septicemia. 3, 19 This serious and widespread disease causes major economic losses in the duck industry through high mortality, reduced growth rate, poor feed conversion, increased condemnations, and high treatment costs. 3 The occurrence of different serotypes of R. anatipestifer in field cases has been reported. 2, 3, 5, 7, 18 Unfortunately, no cross-protection has been observed with inactivated bacterins made from different serotypes of R. anatipestifer. 16 This lack of cross-protection seriously limits the usefulness of immunization in controlling this disease. Consequently, chemotherapy is very important in the treatment of ducks infected with R. anatipestifer.
The availability of ceftiofur, a third-generation cephalosporin antibiotic, which is active against many gram-positive and gram-negative bacteria, provided the impetus for a study in which ceftiofur and 16 other antimicrobial agents were compared for their potential usefulness in controlling R. anatipestifer infections in ducks. 11 The in vitro minimum inhibitory concentrations (MICs) of 17 antimicrobial agents against field isolates of R. anatipestifer were determined. The therapeutic efficacy of ceftiofur against R. anatipestifer infection was determined in ducks inoculated with a virulent strain of the organism.
Materials and methods
Bacterial strains. Fifty strains of R. anatipestifer were chosen, all isolated from ducks with infectious serositis, and serotyped at the Laboratory of Clinical Microbiology, Department of Veterinary Medicine, National Taiwan University. American Type Culture Collection (ATCC) quality control strains, Escherichia coli ATCC 25922, Enterococcus faecalis ATCC 29212, and Pseudomonas aeruginosa ATCC 27853, were used in this study. 6, 8 The test strains were stored at Ϫ70 C before testing.
In vitro susceptibility tests. Agar-dilution MIC tests were conducted as previously described. 6, 8 The following antimicrobial agents were tested: amikacin, ampicillin, ceftiofur sodium, cephalothin, chloramphenicol, flumequine, gentamicin, kanamycin, lincomycin, nalidixic acid, nitrofurantoin, penicillin, spectinomycin, streptomycin, sulfamethoxazole, tetracycline, and trimethoprim. With the exception of ceftiofur, which was provided by the Pharmacia & Upjohn Pharmaceutical Company, a all other antimicrobials were purchased from Sigma. b The dilution ranges used for these antimicrobial agents were 0.03-256 g/ml, except sulfamthoxazole with 0.5-512 g/ml. Inoculum was dispensed, with a replicator c housing 3-mm pins.
Selection and preparation of the most virulent strain for infection. A total of forty-eight, 4-week-old, 600-700 g ducks were used to determinate the virulence of the 7 different R. anatipestifer serotypes. The ducks were distributed randomly into 7 treatment groups and 1 control group. Among them, 1 group served as control. There were 3 male and 3 female ducks in each group. The ducks received drinking water and antibiotic-free commercial feed ad libitum. The most virulent R. anatipestifer strain, as judged by duck mortality, was grown on tryptic soy agar d supplemented with sheep blood (5%, v/v) for 18 hr at 37 C. The cells were harvested by scraping and suspending them in 0.85% sterile saline. A suspension containing 9 ϫ 10 9 CFU/ml, as determined by plate count, was used to infect the experimental ducks. In vivo ceftiofur efficacy. Four groups of ducks (30 ducks per group) were treated with various doses of ceftiofur (0.25, 0.5, 1.0, and 2.0 mg/kg body weight, respectively). Controls (10 ducks per group) were either untreated or injected with saline but not challenged with R. anatipestifer. Except for the saline control group, all ducks were infected by injecting 1 ml of saline containing 9 ϫ 10 9 CFU of the highly virulent isolate of R. anatipestifer into the infraorbital sinus. Ceftiofur was dissolved in sterile deionized water and injected subcutaneously into the neck of each duck 5 hr after infection. Mortality was recorded daily for 2 wk after treatment. Ducks that died were necropsied and the heart, liver, lung, brain, and air sac were cultured on tryptic soy agar d containing 5% sheep red blood cells for the isolation of R. anatipestifer. All ducks surviving at the end of the experiment were sacrificed and examined for pathological lesions.
Results
Because interpretive criteria with R. anatipestifer isolated from ducks are not available for all antimicrobial agents tested, isolates in the present study should not be classified as susceptible or resistant; therefore, only MIC data are presented. The in vitro activities of various antimicrobials against isolates of R. anatipestifer are listed in Table 1 , and the MICs are provided in Table 2 . The 5 most potent antibacterials based on MIC 90 values in descending order were penicillin (16 g/ml), ceftiofur (32 g/ml), cephalothin (64 g/ml), chloramphenicol (64 g/ml), flumequine (64 g/ml), and kanamycin (64 g/ml each). Nalidixic acid, nitrofurantoin, and sulfamethoxazole had MIC 90 values of 128 g/ml. The MIC 90 values of amikacin, ampicillin, gentamicin, lincomycin, spectinomycin, streptomycin, tetracycline, and trimethoprim were Ն256 g/ml.
On the basis of MIC 50 values, the 4 most potent antimicrobials and their rank order were the same as based on MIC 90 values, although their concentration values were reduced with penicillin (2 g/ml), ceftiofur (4 g/ml), chloramphenicol (8 g/ml), and flumequine (8 g/ml). The MIC 50 of cephalothin and nitrofurantoin was 16 g/ml; ampicillin, kanamycin, nalidixic acid, and spectinomycin was 32 g/ml; gentamicin streptomycin, sulfamethoxazole, and tetracycline was 64 g/ml; the remaining antimicrobials was 128 g/ml. The MIC 70 of ceftiofur was 8 g/ ml; flumequine and penicillin was 16 g/ml; cephalothin, chloramphenicol, and nitrofurantoin was 32 g/ ml; kanamycin and nalidixic acid was 64 g/ml; ampicillin, gentamicin, spectinomycin, streptomycin, sulfamethoxazole, tetracycline, and trimethoprim was 128 g/ml; amikacin and licomycin had the highest Table 2) . Serotyping of the isolates yielded 7 different serotypes that were tested for virulence using mortality as the criterion (Table 3) . A representative isolate of each serotype was chosen at random for testing. The representative of serotype 1, strain number RA-45, which caused 100% mortality (Table 3) , was clearly the most virulent and was used as the challenge strain in efficacy test.
Ceftiofur, given as a single subcutaneous dose 5 hours after an infraorbital challenge with the RA-45, reduced mortality in a dose-related fashion, from 90% in the untreated controls to about 27% in ducks receiving 2 mg/kg (Table 4 ). Similarly, the median time of death of the ducks more than doubled from 2.0 days in the untreated control group to 4.5 days in the groups receiving 1.0 or 2.0 mg/kg of ceftiofur. It should be noted that the MIC value of this organism was 0.5 g/ ml that was less than the susceptible MIC breakpoint, 2 g/ml, of cattle and swine pathogen. 8 The ducks infected experimentally with R. anatipestifer serotype-1 exhibited signs of listlessness, ocular discharge, and swollen eyelids at 5 hours after challenge. Ducks that died from R. anatipestifer infection had macroscopic lesions of pericarditis, perihepatitis, meningitis, and fibrinous airsacculitis. Riemerella anatipestifer was isolated from all lesions as well as from the brain. Some of the surviving ducks that received lower doses of ceftiofur were emaciated and showed incoordination, shaking of the head, torticollis, and loss of righting reflex, suggesting severe neural signs. However, none of these signs was observed in surviving ducks that had received ceftiofur at the highest dose (2 mg/kg) given.
Discussion
The in vitro susceptibility of veterinary pathogens to antimicrobials can provide valuable guidance in the choice of chemotherapy. Only a limited amount of data is available on the MICs of antimicrobial agents against R. anatipestifer. 1 A previous report showed that all 5 strains of R. anatipestifer, isolated from ducks in the United States, grew on Mueller-Hinton containing kanamycin at a concentration of 532.8 g/ ml. 1 In contrast, all isolates were inhibited by kanamycin at a concentration of 128 g/ml in this study. The difference in antimicrobial activity against isolates from the 2 countries could be attributed to many factors. 20 Variations in antimicrobial agent usage from one country to another could be a reason. Another factor could be differences in the serotypes of an organism from one country to another. Previous report showed differences in antibiograms on the basis of the serotypes of US Streptococcus suis isolates. 12 There are no authentic MIC values of antimicrobial agents against R. anatipestifer other than kanamycin available to date, so no comparison can be addressed further.
The use of induced disease models in evaluating the efficacy of antimicrobials in ducks has been documented. The use of flumequine for the control of mortality in experimental R. anatipestifer infections 13 as well as the reduction of mortality in R. anatipestiferinfected ducks by the application of lincomycin and spectinomycin, penicillin and streptomycin, oxytetracycline, and spectinomycin, respectively, has been reported. 17 The R. anatipestifer isolates used in the current study were composed of 7 serotypes, 3 of which did not cause mortality when single isolates chosen randomly were injected into ducks. This finding necessitated a preliminary experiment to find a lethal isolate because mortality was the criterion for evaluating efficacy of an antibacterial. The serotype-1 isolate that caused 100% mortality in the preliminary experiment and was susceptible to ceftiofur appeared ideal for such experimental purposes.
Ceftiofur, a broad-spectrum cephalosporin antibiotic that had not been previously tested in ducks, reduced mortality from 90 to 27% and more than doubled the median time to death when administered at 2.0 mg/kg in the experimental model. In addition, the survivors at this dose level did not exhibit any of the adverse signs characteristic of infectious serositis, which were observed in survivors or groups receiving lower doses. The findings of the present study imply that ceftiofur is as useful as other antimicrobials in the practical control of bacterial infections common to the duck industry, despite development of resistance factors. Although the most convenient method of administration of antimicrobials to ducks is through the feed, parenteral administration of ceftiofur was studied as a means of treating sick birds individually.
Antimicrobial resistance can be plasmid, chromosome, or transposon mediated (or all) in bacteria. 15 Two plasmids from R. anatipestifer have been previously characterized, both carried a virulence-associated gene but no antibiotic resistant genes. 4, 21 This indicates that the antimicrobial resistance in R. anatipestifer is probably chromosome mediated. The genetic mechanism of chromosome-mediated antimicrobial resistance in R. anatipestifer is unknown. Studies of other bacteria, including E. coli, P. aeruginosa, Nesseria gonorrhoeae, and Haemophilus influenzae, have indicated that there are multidrug resistance (MDR) efflux systems. 9, 10, 14 The MDR efflux system has been classified into 4 transporter families; the ATP-binding cassette superfamily, the major facilitator superfamily, the small drug resistance family, and the resistance-nodulation-cell division (RND) family. 14 It is known that RND family transporters can actively export a wide variety of antibiotics in gram-negative organisms. 9 Determination of whether or not the antibiotic resistance in R. anatipestifer belongs to this family awaits further studies.
